Genmab — April 2017
-
http://www.ascopost.com/issues/april-25-2017/adding-daratumumab-to-lenalidomidedexamethasone-increases-progression-free-survival-in-previously-treated-multiple-myeloma/ http://www.ascopost.com/issues/april-25-2017/monoclonal-antibody-therapy-with-daratumumab-in-multiple-myeloma-expanding-therapeutic-horizons/ 2 articles in ASCO Post, no news really I think, more a summary maybe in anticipation of ASCO
-
Fine artikler E L. Jeg plejer at hylde det princip, at når P. Richardson åbner munden, så gælder det om at åbne ørerne. Her nærmest skamroser han - lidt usædvanligt for en ellers forsigtig mand - dara, og afventer "eagerly", at der kommer resultater fra frontline-studierne.
-
Trump vil skære i støtten til pharma og biotek. http://medwatch.dk/Medicinal___Biotek/article9528284.ece
-
God morgen.
-
For læg mand er vi i en nyhedsfattig periode. Det betyder, at sådanne meldinger fra Trumpeten kan få betydning psykologisk. EU godkendelsen, som må komme snart, er indregnet og vil ikke flytte kursen noget særligt. Måske skal vi lige teste 1300 en af dagene?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind